Radiopharm Theranostics Limited (RADX)

Radiopharm Theranostics Statistics

Total Valuation

RADX has a market cap or net worth of $41.60 million. The enterprise value is $21.38 million.

Market Cap	41.60M
Enterprise Value	21.38M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

RADX has 2.36 billion shares outstanding. The number of shares has increased by 438.49% in one year.

Current Share Class	n/a
Shares Outstanding	2.36B
Shares Change (YoY)	+438.49%
Shares Change (QoQ)	+26.72%
Owned by Insiders (%)	10.76%
Owned by Institutions (%)	14.59%
Float	1.60B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.07
Forward PS	n/a
PB Ratio	1.48
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.67

Current Ratio	2.67
Quick Ratio	2.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-537.99

Financial Efficiency

Return on equity (ROE) is -109.20% and return on invested capital (ROIC) is -62.53%.

Return on Equity (ROE)	-109.20%
Return on Assets (ROA)	-27.70%
Return on Invested Capital (ROIC)	-62.53%
Return on Capital Employed (ROCE)	-49.10%
Revenue Per Employee	$585,935
Profits Per Employee	-$1.80M
Employee Count	14
Asset Turnover	0.16
Inventory Turnover	n/a

Taxes

In the past 12 months, RADX has paid $67,719 in taxes.

Income Tax	67,719
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.91
52-Week Price Change	n/a
50-Day Moving Average	6.11
200-Day Moving Average	5.11
Relative Strength Index (RSI)	47.23
Average Volume (20 Days)	29,453

Short Selling Information

The latest short interest is 34,392, so 0.00% of the outstanding shares have been sold short.

Short Interest	34,392
Short Previous Month	43,807
Short % of Shares Out	0.00%
Short % of Float	0.00%
Short Ratio (days to cover)	1.04

Income Statement

In the last 12 months, RADX had revenue of $8.20 million and -$25.14 million in losses. Loss per share was -$0.01.

Revenue	8.20M
Gross Profit	-12.19M
Operating Income	-23.03M
Pretax Income	-25.07M
Net Income	-25.14M
EBITDA	-21.33M
EBIT	-23.03M
Loss Per Share	-$0.01

Balance Sheet

The company has $19.09 million in cash and n/a in debt, giving a net cash position of $19.09 million or $0.01 per share.

Cash & Cash Equivalents	19.09M
Total Debt	n/a
Net Cash	19.09M
Net Cash Per Share	$0.01
Equity (Book Value)	28.11M
Book Value Per Share	0.01
Working Capital	16.34M

Cash Flow

Operating Cash Flow	-24.03M
Capital Expenditures	n/a
Free Cash Flow	-23.77M
FCF Per Share	-$0.01

Margins

Gross Margin	-148.63%
Operating Margin	-280.77%
Pretax Margin	-305.62%
Profit Margin	n/a
EBITDA Margin	-260.03%
EBIT Margin	-280.77%
FCF Margin	n/a

Dividends & Yields

RADX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-438.49%
Shareholder Yield	-438.49%
Earnings Yield	-60.42%
FCF Yield	-57.12%

Analyst Forecast

The average price target for RADX is $15.00, which is 125.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	125.90%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	70.67%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RADX has an Altman Z-Score of -2.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.43
Piotroski F-Score	4